Newly approved drug for metastatic melanoma nearly doubles median survival
Thursday, February 23, 2012 - 11:30
in Health & Medicine
A newly approved drug for patients with metastatic melanoma nearly doubles median survival times, a finding that will change the way this deadly form of skin cancer is treated.